Back to User profile » Mr Patrick Hlavacek
Papers published by Mr Patrick Hlavacek:
Real-World Treatment Patterns of Elranatamab in Patients with Multiple Myeloma in Japan: The EVEREST Study
Yoshihara S, Meche A, Hlavacek P, Johnson SM, Demers AS, Nador G, Ikoma S, Yadav CP, Assaf CA, DiBonaventura M, Chen Y
ClinicoEconomics and Outcomes Research 2026, 18:581258
Published Date: 11 March 2026
An Updated Indirect Comparison of Elranatamab Versus a Real-World External Control Arm in Triple-Class Refractory Multiple Myeloma
Costa LJ, LeBlanc TW, Tesch H, Sonneveld P, Johnson SM, Vekeman F, Hlavacek P, Meche A, Kim CH, Cislo P, Hughes DM, Nador G, DiBonaventura M
Blood and Lymphatic Cancer: Targets and Therapy 2025, 15:11-20
Published Date: 5 June 2025
Matching-Adjusted Indirect Comparison of Elranatamab versus Teclistamab in Patients with Triple-Class Exposed/Refractory Multiple Myeloma: Updated Results
Mol I, Hu Y, LeBlanc TW, Cappelleri JC, Chu H, Nador G, Aydin D, Perez Cruz I, Hlavacek P
Journal of Blood Medicine 2025, 16:233-239
Published Date: 14 May 2025
Economic Impact of Elranatamab for Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Shah B, Sandin R, Liu Y, Bobolts LR, Hu Y, Mol I, Schepart A, Hughes DM, Hart J, Hlavacek P
ClinicoEconomics and Outcomes Research 2025, 17:289-302
Published Date: 8 April 2025
Multiple Myeloma Experiences and Preferences: A Mixed Methods Study of Patients and Care Partners in the United States
Flora DR, Byrd R, Platt DA, Hlavacek P, Hoag Goldman E, Cappelleri JC, Kennedy CT, LeBlanc TW
Patient Preference and Adherence 2025, 19:963-979
Published Date: 8 April 2025
Patient and economic burdens of postherpetic neuralgia in China
Yu SY, Fan BF, Yang F, DiBonaventura M, Chen YX, Li RY, King-Concialdi K, Kudel I, Hlavacek P, Hopps M, Udall M, Sadosky A, Cappelleri JC
ClinicoEconomics and Outcomes Research 2019, 11:539-550
Published Date: 3 September 2019
Epidemiology of physician-diagnosed neuropathic pain in Brazil
Udall M, Kudel I, Cappelleri JC, Sadosky A, King-Concialdi K, Parsons B, Hlavacek P, Hopps M, Salomon PA, DiBonventura MD, Clark P, Santos Garcia JB
Journal of Pain Research 2019, 12:243-253
Published Date: 7 January 2019
Characteristics of patients with neuropathic pain syndromes screened by the painDETECT questionnaire and diagnosed by physician exam
Kudel I, Hopps M, Cappelleri JC, Sadosky A, King-Concialdi K, Liebert R, Parsons B, Hlavacek P, Alexander AH, DiBonventura M, Markman JD, Farrar JT, Stacey BR
Journal of Pain Research 2019, 12:255-268
Published Date: 7 January 2019
Systematic literature review of treatment patterns for venous thromboembolism patients during transitions from inpatient to post-discharge settings
Trocio J, Rosen VM, Gupta A, Dina O, Vo L, Hlavacek P, Rosenblatt L
ClinicoEconomics and Outcomes Research 2019, 11:23-49
Published Date: 19 December 2018
The prevalence of probable neuropathic pain in the US: results from a multimodal general-population health survey
DiBonaventura MD, Sadosky A, Concialdi K, Hopps M, Kudel I, Parsons B, Cappelleri JC, Hlavacek P, Alexander AH, Stacey BR, Markman JD, Farrar JT
Journal of Pain Research 2017, 10:2525-2538
Published Date: 1 November 2017
Humanistic and economic burden of fibromyalgia in Japan [Corrigendum]
Lee LK, Ebata N, Hlavacek P, DiBonaventura M, Cappelleri JC, Sadosky A
Journal of Pain Research 2016, 9:1161-1162
Published Date: 5 December 2016
Humanistic and economic burden of fibromyalgia in Japan
Lee LK, Ebata N, Hlavacek P, DiBonaventura M, Cappelleri JC, Sadosky A
Journal of Pain Research 2016, 9:967-978
Published Date: 4 November 2016